Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Adjuvant Goserelin in Locally Advanced Prostate Cancer
NCT00767286Phase 3Completed
- Sponsor
- NRG Oncology
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of goserelin in prostate cancer (PCa), sponsored by NRG Oncology. Status: completed.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00767286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767286.